of the following parts: -page 11, line 211 -"screen detected cancers are mainly of low grade" -did you mean "stage", not "grade"? This sentence is too long.
-page 11, line 216 -data on "overall screening participation are not available". You have mentioned in the limitations of the study that participation rate (or other performance indicators of screening programmes) are not available. Do you have any explanation about the reasons why indicators recommended for monitoring and evaluation of screening programmes are not reported in your country? -page 11, line 219 "at the level of cancer occurrence" -did you mean stage at diagnosis? -page 11, line 221 "the interpretability with regard to screening is limited" -this is a correct statement, based on your results, but when reading the title of your paper the impression is that the evidence is more solid. Would you consider slightly rephrasing the title? -page 11, line 223 -did you mean fig. A1 ? Other comments: -page 3, line 53 -since you haven't evaluated the progress in cancer management in your study, the statement "mainly driven by progress in cancer management" has to be softened. -page 5, line 91 -"health and health related behaviour" -it is worthy to mention also the prevalence of hormone replacement therapy, age at first birth, number of births, etc. and add corresponding references related to your country. -page 5, lines 103-105 needs clarification -page 5, lines 107-109 "We corrected... in the previous study" -this sentence can be moved to Methods. -page 7, line 142 -could you explain why you decided to use all ages combined if your intention was to focus on the effect of screening, which is performed in the certain age range -page 9, line 178 "age specific breast cancer mortality" -is this correct? -page 10, lines 190-191 -clarification is needed -page 12, line 250 -"sufficiently long" -please specify
REVIEWER
Philippe Autier International Prevention research Institute (iPRI), Lyon, France REVIEW RETURNED 06-Aug-2017
GENERAL COMMENTS
The paper of C Herrmann and colleagues explores the factors underpinning the marked reductions in breast cancer mortality that took place over the last 25 years in Switzerland. If the article is of interest, efforts are needed for obtaining an article that will attract the attention of clinicians and of other health professionals, bearing in mind that the vast majority of potential readers are not acquainted with Bayesian statistical methods. To put it bluntly, dozens of papers based on sophisticated statistical modelling have been published with results in favour and not in favour of a role of breast screening in breast cancer mortality reductions observed in most high income countries after 1985. The experience gathered since the 1990s shows that even experts in statistics experience difficulties for figuring out the reasons underlying the huge discrepancies in results obtained by different (Bayesian and non-Bayesian) model approaches. There is thus the need to convince non experts in statistics that first, results of this study are not due to some mathematical trick, and second, that results would not have been different if another statistical modelling approach had been adopted. In this regard, my main comment is about the necessity to first show descriptive data suggesting an absence of correlation between participation to breast screening and trends in breast cancer mortality, followed by the modelling approach that would c onfirm that descriptive data are most probably not due to some confounding. There is at present no real evidence that any dietary factor would represent a risk factor for breast cancer apart from alcohol intake, the Mediterranean diet (weak factor -eg, Toledo et al, JAMA Int Med, 2015) and total energy intake. Authors need to be specific about these issues.
5/ In the Introduction, the following sentence is incorrect: "Differences in access to mammography screening and in lifestyle may be reflected in spatio-temporal differences of both, breast cancer incidence and mortality, whereas only the latter will reflect the management of breast cancer". Lifestyle-related factors such as type 2 diabetes and obesity influence the risk of breast canc er death, because these factors are associated with more aggressive cancers and diabetic patients are more sensitive to adverse events of therapies. Hence spatio-temporal differences in these factors might explain differences in breast cancer mortality rates. I would suggest to skip the sentence.
REVIEWER

Peter Baade
Cancer Council Queensland Australia REVIEW RETURNED 28-Aug-2017
GENERAL COMMENTS
I was surprised by the choice of indicator for screening -as in the number of years of population-based screening. I would have thought it more important to look at screening participation rate, and assess how that rate varied across the different municipalities.
The median population of the municipalities is relatively small, at about 1,100 people per area. When considering only women, this would decrease even further. What is the median number of women who die from breast cancer in each area? It must be very small. Do these very small numbers of cases per area give sufficient capacity to identify any changes in these spatial patterns over time?
On a broader scale, the key measures of interest would be whether there is an interaction between time period and screening "intensity" (however that is measured). By presenting only main effects, it was not clear to me what the purpose of Table 1 is.
No information about the uncertainty of the spatial estimates has been provided.
Can you provide an explanation of the "Spatial variation" components in Tables 1 and 2 , and how this corresponds to the nearly identical parameter estimates for the non-spatial and spatial models?
Given that the screening programs are organised at the cantonal level, has this been incorporated into the spatial models?
The results of ref #16 appear to be the same as for this one, with the main difference being an extra year of data. Given that ref #16 found no if any spatial patterns in breast cancer mortality by municipality, then adding details of screening will not alter the lack of spatial patterns. It would help to make it clearer what this current study adds to the findings of ref #16. Figure A1 -for screening program prevalence -the shading colours were very difficult to distinguish when printed in grey scale -can this be a more print friendly colour scheme, preferably a graduation in colour?
VERSION 1 -AUTHOR RESPONSE
Dear Editors, thank you for the opportunity to revise our manuscript. Please find our responses to the reviewers' requests below.
Kind regards Christian Herrmann
Editorial Requests: -Please revise your title. We ask authors to refrain from using declarative titles (i.e thos e that state the study's main findings). Please revise your title so that it frames the research question and includes the research design. ⇒ Title was changed to: Spatio-temporal modelling of breast cancer mortality in a country with different regional screening policies -Please remove the 'what is already known' and 'what this study adds' sections (these are not journal requirements). ⇒ Was removed -Please improve the 'Strengths and Limitations' section on page 3. Each bullet point should be a separate/ self-contained strength or limitation of your study. The section should contain up to five short bullet points, no longer than one sentence each, that relate specifically to the methods or design of the study reported (see: http://bmjopen.bmj.com/site/about/guidelines.xhtml#articletypes).
⇒
We improved that section accordingly: • Modern Bayesian spatial model were used to improve estimation of an unstable rate by "borrowing" strength from its neighbours.
• The used model is capable to assess the significance of risk factors taking into account the geographical correlation.
• Switzerland with its homogeneous health system and different regional screening policies provides an ideal setting for assessing the impact of population based mammography screening programmes.
• Data on the geographical differences in opportunistic screening use and therefore overall screening participation are not available, •
The ecological study design does not allow an assessment of the combined impact of participation in and type (programme vs. opportunistic) of mammography screening.
-Please thoroughly check the manuscript for grammatical/ typographical errors (e.g. abstract: "other investigated factors where"; introduction: "we aimed asses" etc.) ⇒ We had additional language editing done by a native speaker.
Reviewers' Comments to Author:
Reviewer: 1 Reviewer Name: Gabriel Escarela Institution and Country: Universidad Autónoma Metropolitana -Iztapalapa, Mexico Competing Interests: None declared The title of the paper is: "Breast cancer mortality reduction predominantly driven by progress in management". However, the abstact suggests that the main research is on assessing the effect on mammography programs. It gives me the impression that the authors imply that, since duration of population based screening programme, socioeconomic position, urbanisation and language region have no signifficant effects, by elimination breast cancer mortality reduction is due to management. Epidemiol. 2006; 164:1003 -1011 , and thus it seems reasonable to speculate that the effects of age at diagnosis on the cause of death have changed as well, taking into account that menopause can be an important threshold between 2 age-related etiologic mechanisms. Does your dataset lends itself to solve this question? ⇒ We agree that the message of the title was not fully discussed in the manuscript as the main aim was in fact assessing the effect of mammography screening programmes and the outcome of the study could have been better summarized. We changed the title to "Spatio-temporal modelling of breast cancer mortality in a country with different regional screening policies". We think that the previous title contained a valid assumption, since progress in cancer management have led to a strong increase in survival after breast cancer diagnosis coinciding in time with the decrease in mortality. We agree that several time dependent factors influence the occurrence of breast cancer death (note: BC incidence is still increasing). However an in depth-analysis would have been out of the scope of our research question.
Reviewer: 2 Reviewer Name: Nadya Dimitrova Institution and Country: University Hospital of Oncology, Bulgaria Competing Interests: None declared Dear Authors, Your study on factors influencing breast cancer mortality trend in Switzerland is providing an important contribution to the understanding of this topic. The opportunity to compare regions with similar organisation of health care, but different policy on screening is advantageous. The objective of the study is clear, materials and methods are appropriate, the results are presented in well structured tables and informative figures. The discussion needs some revision of the following parts: -page 11, line 211 -"screen detected cancers are mainly of low grade" -did you mean "stage", not "grade"? This sentence is too long. ⇒ Was changed accordingly: The reasons for this are probably manifold and may include the fact that screen detected cancers are mainly of low stage, many women have not participated in the screening programmes or have chosen to undergo opportunistic screening. In addition, the effect of advances in diagnosis and therapy on mortality is quite strong and may have outweighed benefits from population based screening programmes, as suggested by Autier et al.
-page 11, line 216 -data on "overall screening participation are not available". You have mentioned in the limitations of the study that participation rate (or other performance indicators of screening programmes) are not available. Do you have any explanation about the reasons why indicators recommended for monitoring and evaluation of screening programmes are not reported in your country? ⇒ We have clarified this issue. Overall participation in this context refers to screening within and outside of population based screening programmes. For the latter -and hence the sum-no data is available. In Switzerland, only data on "ever been screened" is collected within the health survey. The results of this survey are based on questionnaires and they cannot answer the question on the regular attendance or attendance rate by type of screening. Data on participation in screening within or outside of a population based programme was assessed for selected years and regions within few studies. Comprehensive data on voluntary screening use would only be available from the high number of health insurance companies. Data on participation in population based screening programmes are published in a national monitoring report and rates are nearly identical across the programmes.
-page 11, line 219 "at the level of cancer occurrence" -did you mean stage at diagnosis? ⇒ Yes, was changed accordingly.
-page 11, line 221 "the interpretability with regard to screening is limited" -this is a correct statement, based on your results, but when reading the title of your paper the impression is that the evidence is more solid. Would you consider slightly rephrasing the title? ⇒ We changed the title to "Spatio-temporal modelling of breast cancer mortality in a country with different regional screening policies" -page 11, line 223 -did you mean fig. A1 ? ⇒ Yes, was changed accordingly. Other comments: -page 3, line 53 -since you haven't evaluated the progress in cancer management in your study, the statement "mainly driven by progress in cancer management" has to be softened. ⇒
The whole section was deleted based on editor request. -page 5, line 91 -"health and health related behaviour" -it is worthy to mention also the prevalence of hormone replacement therapy, age at first birth, number of births, etc. and add corresponding references related to your country. ⇒ We included this as suggested. We have no data on geographical differences in HRT and have included a paragraph in the discussion section, discussing the possible influence of HRT: "I.e. while a temporary increase in the use of hormone replacement therapy has led to an increase in breast cancer incidence, many of those tumours have a favorable prognosis and might have influenced breast cancer mortality only marginally." -page 5, lines 103-105 needs clarification ⇒ We adjusted the sentence accordingly. A stronger reduction in younger age groups may have been in part due to a shift from deaths in the next older age group due to prolonged survival and since age at death was used.
-page 5, lines 107-109 "We corrected... in the previous study" -this sentence can be moved to Methods. ⇒ The Method section already includes the mention of urbanisation as additional factor. We prefer to leave this sentence, as it describes the improvements towards a previous study and the respective rationale for these. -page 7, line 142 -could you explain why you decided to use all ages combined if your intention was to focus on the effect of screening, which is performed in the certain age range ⇒ Our intention was to show the effect of population based screening on BC mortality on population level. Therefore it is necessary to use all ages combined. Furthermore, a criticism of dividing the analysis into age groups in order to assess screening impact was: "Data based on fixed age-groups and time periods, will include too many unscreened women or women who had their breast cancer diagnosis before invitation to screening. Based on these data on fixed age-groups and time periods authors can therefore NOT say anything about mammography screening." -page 9, line 178 "age specific breast cancer mortality" -is this correct? ⇒ Was changed to "age standardised". -page 10, lines 190-191 -clarification is needed ⇒ Here we described the values the socio-economic index (SEP) among the municipalities. The model results describe the effect of a 10 point increase in SEP on BC mortality, therefore it is important to know the baseline values. -page 12, line 250 -"sufficiently long" -please specify ⇒ This refers to the respective line in the discussion (220-221) where we cite 27. The paper of C Herrmann and colleagues explores the factors underpinning the marked reductions in breast cancer mortality that took place over the last 25 years in Switzerland. If the article is of interest, efforts are needed for obtaining an article that will attract the attention of clinicians and of other health professionals, bearing in mind that the vast majority of potential readers are not acquainted with Bayesian statistical methods. To put it bluntly, dozens of papers based on sophisticated statistical modelling have been published with results in favour and not in favour of a role of breast screening in breast cancer mortality reductions observed in most high income countries after 1985. The experience gathered since the 1990s shows that even experts in statistics experience difficulties for figuring out the reasons underlying the huge discrepancies in results obtained by different (Bayesian and non-Bayesian) model approaches. There is thus the need to convince non experts in statistics that first, results of this study are not due to some mathematical trick, and second, that results would not have been different if another statistical modelling approach had been adopted. In this regard, my main comment is about the necessity to first show descriptive data suggesting an absence of correlation between participation to breast screening and trends in breast canc er mortality, followed by the modelling approach that would confirm that descriptive data are most probably not due to some confounding.
We already have provided the results of both a non-spatial and a spatial (Bayesian) model. One can see very clearly that results among both models are concordant. Furthermore, Bayesian models have been proven to be very solid and very effective models over several decades now. Confounding was already very clearly accounted for in the manuscript. More specifically: 1/ Data on attendance to mammography screening by Swiss language regions are available at http://www.bfs.admin.ch/ (ie, the Swiss Health Surveys that capture both opportunistic and organised screening). In 2012 about 35% of German-speaking and 70% of French or Italian speaking women 45-74 years of age had at least one mammography (for screening or diagnosis purpose) in the last two years. I suggest a graph on breast cancer mortality rates (adjusted for European standard population and for the Lutz correction) for the French/Italian-speaking regions and German-speaking regions, showing no differences in trends over time (ie, the results of the BMC Cancer paper displayed in a more classic way). Probably that authors could have access to Swiss Health Survey data for smaller areas and for more years, which would increase the time and geographical resolution of participation to screening. If available, statistical models could incorporate these statistics on participation to screening. ⇒ We have clarified this issue. Overall participation in this context refers to screening within and outside of population based screening programmes. For the latter -and hence the sum-no data is available. In Switzerland, only data on "ever been screened" is collected within the health survey. The results of this survey are based on questionnaires and they cannot answer the question on the regular attendance or attendance rate by type of screening. Data on participation in screening within or outside of a population based programme was assessed for selected years and regions within few studies. Comprehensive data on voluntary screening use would only be available from the high number of health insurance companies. Data on participation in population based screening programmes are published in a national monitoring report and rates are nearly identical across the programmes. 2/ The modelling approach needs to be described in plain language, with a true attempt to explain a complex approach to non-experts. Referring to the BMC article for details is appropriate, but an article in the BMJ Open needs an outline of methods that can be understood by clinicians. ⇒
In the Methods section we have referenced a previous article for detailed mathematical formulation, and we also summarized the methodology in plain text (Lines 145-152 ). In the article summary section preceding the main text we mentioned that "strengths of Bayesian spatial models are their improvement of estimation of an unstable rate by "borrowing" strength from its neighbours, and they can also assess the significance of risk factors taking into account the geographical correlation" 3/ The Introduction is too long. Several sentences are not relevant (see below) and could be deleted.
We have taken this into consideration, also see below. 4/ Page 6 line 114: It is not clear whether the data from the Swiss Federal Statistical office were individual data or aggregated data (the latter is suggested some lines below)? ⇒ They provided anonymized, individual data (see line 116). 5/ The English needs attention. The text should be edited by an author whose mother tongue is English.
We performed additional language editing. Other comments: 1/ The syntax should be specific to the subject: on page 4 line 53, the "overall mortality trend" is not correct as this refers to all-cause mortality and not to breast cancer specific mortality. ⇒ The whole section was deleted based on editor request. 2/ Introduction: page 4, the lines 71 to 80 are for the Discussion. ⇒
We believe this paragraph is better suited for the introduction, since it provides the rationale for the presented study. 3/ Page 5, lines 103-105 are not clear. Survival statistics should be avoided when screening is the topic being studied. ⇒ This line refers to limitations of a previous study. 4/ In the Introduction, the following sentence is questionable: "In addition, considerable differences in health and health related behaviour -affecting the risk of breast cancer-have been reported for the Swiss language regions including alcohol intake, smoking and healthy diet [13 14] ." If smoking is now recognised as a risk factor for breast cancer, its influence remains marginal compared to reproductive factors and alcohol drinking and metabolic conditions like diabetes. There is at present no real evidence that any dietary factor would represent a risk factor for breast cancer apart from alcohol intake, the Mediterranean diet (weak factor -eg, Toledo et al, JAMA Int Med, 2015) and total energy intake. Authors need to be specific about these issues.
We removed the mention of smoking. 5/ In the Introduction, the following sentence is incorrect: "Differences in access to mammography screening and in lifestyle may be reflected in spatio-temporal differences of both, breast cancer incidence and mortality, whereas only the latter will reflect the management of breast cancer". Lifestyle-related factors such as type 2 diabetes and obesity influence the risk of breast cancer death, because these factors are associated with more aggressive cancers and diabetic patients are more sensitive to adverse events of therapies. Hence spatio-temporal differences in these factors might explain differences in breast cancer mortality rates. I would suggest to skip the sentence. ⇒ Actually we indicated with that sentence, that lifestyle related factors influence mortality by stating "[…] of both, breast cancer incidence and mortality, […]".
Reviewer: 4 Reviewer Name: Peter Baade Institution and Country: Cancer Council Queensland, Australia Competing Interests: None Declared I was surprised by the choice of indicator for screening -as in the number of years of populationbased screening. I would have thought it more important to look at screening participation rate, and assess how that rate varied across the different municipalities. ⇒ A strength of this study is, that regions with and without organised screening programmes can be compared. This could answer the question what the effect on Breast Cancer mortality would be if a population based screening programme is introduced. The median population of the municipalities is relatively small, at about 1,100 people per area. When considering only women, this would decrease even further. What is the median number of women who die from breast cancer in each area? It must be very small. Do these very small numbers of cases per area give sufficient capacity to identify any changes in these spatial patterns over time?
The used methodology is very well suited to deal with small numbers, which allows usage of smaller geographical units as otherwise possible. We expanded the methods section to further emphasise this point. On a broader scale, the key measures of interest would be whether there is an interaction between time period and screening "intensity" (however that is measured). By presenting only main effects, it was not clear to me what the purpose of Table 1 is. ⇒ That would also be an interesting research question, however, in this study we were interested in the effect of a population based screening programme on the population breast cancer mortality. Table 1 shows the result of the models adressing our researc h question. No information about the uncertainty of the spatial estimates has been provided. ⇒ This is presented in table 1. Can you provide an explanation of the "Spatial variation" components in Tables 1 and 2 , and how this corresponds to the nearly identical parameter estimates for the non-spatial and spatial models? ⇒ In contrast to the non-spatial model, the spatial model takes the spatial relationship of the geographical subunits into account. The "spatial variation" value expresses the amount of spatial correlation, a value of 0 would denote no spatial correlation. Since this is the standard deviation of the spatial random effects, this value is only available for the spatial model. Given that the screening programs are organised at the cantonal level, has this been incorporated into the spatial models? ⇒ Yes, municipalities are the administrative sub-unit of cantons. The results of ref #16 appear to be the same as for this one, with the main difference being an extra year of data. Given that ref #16 found no if any spatial patterns in breast cancer mortality by municipality, then adding details of screening will not alter the lack of spatial patterns. It would help to make it clearer what this current study adds to the findings of ref #16. ⇒
In the Introduction we elaborated the rationale of this study in detail. In short, we were interested in the effect of population based mammography screening on the breast cancer mortality on population level. The previous study design was incapable in answering this question. Therefore a different design was necessary. Not only was screening added as a covariate but also socioeconomic factors and age groups were combined. Figure A1 -for screening program prevalence -the shading colours were very difficult to distinguish when printed in grey scale -can this be a more print friendly colour scheme, preferably a graduation in colour? ⇒ As I understood, the additional material will be published online only. However, if requested by the editors, we will additionally provide a printer friendly version of this figure.
VERSION 2 -REVIEW
REVIEWER
Peter Baade Cancer Council Queensland Australia REVIEW RETURNED 18-Oct-2017
GENERAL COMMENTS
Given this paper reports a null result, in terms of asserting that there is no impact of mammography screening on the spatial variation in breast cancer mortality, it is important to rule out the possibility that the study design has the capacity to detect a difference. I am not convinced that this is the case. My concerns are similar to those I raised in my previous comments. Table 1 , both the spatial and non-spatial models show a suggestion of better survival for more year's participation in a breast screening program. Given the crudeness of the indicator used for breast screening, it is impossible determine whether this is a true "null result", or whether this suggestion of an effect would be more obvious with a more robust study design. 3. Finally, there is still no information about the participation rates in those areas with a screening program, apart from a comment in the discussion about the rates being similar across areas.
REVIEWER
Dimitrova
National Oncological Hospital, Bulgaria REVIEW RETURNED 26-Oct-2017
GENERAL COMMENTS
The paper gives an overview of the breast cancer mortality trends and explores the impact of several factors on the observed trend, including duration of population based screening in regions with different screening policies. The objective is clear, the methods are appropriate and well described, the results are presented in nice tables and figures, the discussion is informative, balanced and presents the strengths and limitations of the study. I don't have any suggestions for corrections.
REVIEWER
Philippe Autier International Prevention Research Institue, France
REVIEW RETURNED
02-Nov-2017
GENERAL COMMENTS
The article of Herrmann and colleagues has much improved. However, in their answers to my comments, authors considered that « Bayesian models have been proven to be very solid and very effective models over several decades now". I somehow regret that authors assumes that most clinicians (the principal audience of the BMJ) understand subtleties of Bayesian model approaches, which prevents a true pedagogic exercise. But I admit that the method section and the related Discussion paragraphs are now more amenable than in the initial submission. The English still need some improvement. For instance, the last sentence of the objectives in the abstract need revision. The same for line 76-77 of page 4. Other comments: 1/ Line 72 of page 4: the study by Olsen et al was on the same areas that that of Kalager et al, used the same design and examined a longer period. Results were identical in both studies and thus the argument of "short observation period" does not hold. 2/ Lines 222 and 223 of page 11: the too short time since screening start is not a valid concern because in French speaking areas, organised screening was already quite widespread in the 1990's. If screening had had an impact on breast cancer mortality, a differential in breast cancer mortality trends according would have influenced the SMR ratio for "5+ years" in the two tables. In this regard, authors should look at the article by Harding et al , displaying results of analyses on breast cancer mortality in small areas in the USA, where variable levels of participation to screening over 20 years have been observed.
